A patient of hypeension on ACE inhibitors developed rosea skin erruptions. True statement regarding this situation is
First, I need to recall why ACE inhibitors can cause skin eruptions. ACE inhibitors are known for causing a dry cough, but rashes can also occur. The mechanism might involve angiotensin II, which is normally broken down by ACE. If the inhibitor blocks ACE, maybe there's an accumulation of bradykinin or something else that affects the skin.
Wait, another angle: some people have an allergic reaction to ACE inhibitors, but that's rare. Or maybe the rash is due to a hypersensitivity reaction. But more commonly, the rash is a side effect, not an allergy. Also, there's a condition called angioedema, which is more severe, but a rash could be a milder form.
The correct statement would be something about the rash being a side effect, not an allergic reaction. So the options probably include something about angioedema, allergic reaction, or stopping the medication immediately. The true statement would be that the rash is a common side effect and doesn't require stopping the drug unless it's severe.
Now, for the incorrect options: one might say it's an allergic reaction, another that it's a sign of angioedema, another that it's a contraindication. Each of those would be wrong because the rash is a known side effect, not an allergy, and angioedema is a different, more severe issue.
Clinical pearl here would be to differentiate between rash as a side effect versus angioedema or true allergy. Also, that ACE inhibitors can be continued unless the rash is severe or accompanied by other symptoms like swelling.
So putting it all together: the core concept is ACE inhibitors causing rashes. The correct answer is that the rash is a side effect, not an allergic reaction. The wrong options would be about allergy, angioedema, or contraindication. The clinical pearl is to distinguish between rash and angioedema.
**Core Concept**
ACE inhibitors (e.g., lisinopril) can cause cutaneous adverse effects due to **bradykinin accumulation**, a known side effect unrelated to hypersensitivity. Bradykinin, normally degraded by ACE, increases vascular permeability and pruritus, leading to rashes. This is distinct from angioedema or true allergic reactions.
**Why the Correct Answer is Right**
The rash in this scenario is a **non-allergic side effect** of ACE inhibitors, mediated by bradykinin accumulation. Bradykinin activates B2 receptors, increasing capillary permeability and causing localized inflammation. Unlike angioedema (which involves subcutaneous swelling), this rash is typically maculopapular and self-limiting, not requiring immediate drug discontinuation unless severe.
**Why Each Wrong Option is Incorrect**
**Option A:** "Rash indicates angioedema" – Incorrect. Angioedema involves deep dermal/submucosal swelling, not a superficial rash.
**Option B:** "Rash is an allergic reaction" – Incorrect. Allergic reactions (e.g., urticaria, anaphylaxis) involve IgE-mediated mast cell degranulation, which is distinct from bradykinin-driven rashes.